We’ve just returned from an exciting week at the #CMSC25 Annual Conference in Phoenix, AZ, the premier North American event for healthcare professionals and researchers in Multiple Sclerosis (MS) care.
As the world leader in gait measurement for MS, our Celestra Health research team was selected to present our research highlighting our stellar benchmarking results compared to a state-of-the-art gait laboratory, as well as our strong correlations with existing MS clinical measures, such as the Expanded Disability Status Scale (EDSS) and the Timed 25 Foot Walking test.
We are delighted to have made so many connections, both in our exhibitor booth as well as during the research presentation session. The feedback we received was overwhelmingly positive, given the widely recognized challenges of objectively measuring MS patient gait and the importance of “getting it right” by combining laboratory-grade accuracy with patient ease-of-use.
With 50+ interested parties that we met during the conference, we’re now actively engaging with leading MS clinics across the US to expand access to our platform and improve outcomes for people living with MS.
We’re grateful to the CMSC community for the opportunity to share our work and can’t wait to build on the momentum.
From left to right: Todd Huckabone, Customer Success Specialist at Celestra Health and Bruce Ford, President & CEO at Celestra Health
